SCHEMBL5048360

SCHEMBL5048360

Cc1cc(C)cc(C[SiH2]CCOC(=O)N(C)[C@@H](CC[C@@H]2CCCOC2)NC(=O)OC(C)(C)C)c1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CACNA1B Q00975 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2325866 0.80 CTSS (0.34) KMT2A
SCHEMBL2325868 0.80 CTSS (0.34) KMT2A
SCHEMBL5048357 0.77 CTSS (0.32) KMT2A
SCHEMBL5048364 0.77 CTSS (0.32) KMT2A
SCHEMBL2359147 0.70 METAP2 (0.30)
SCHEMBL2361211 0.70 METAP2 (0.30)
SCHEMBL2360808 0.70 METAP2 (0.30)
SCHEMBL3615999 0.66 GPR119 (0.32) KMT2A
SCHEMBL3615998 0.66 GPR119 (0.32) KMT2A
SCHEMBL2325873 0.64 CTSK (0.32) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed